Open access
Open access
Powered by Google Translator Translator

Daily Archives: February 5, 2021

Cohort study: Increased consumption of refined grains linked to higher risk of mortality and major cardiovascular disease events

5 Feb, 2021 | 01:30h | UTC

Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study – The BMJ

Commentaries: Refined carbs like white bread, pasta, and pastries could increase risk of early death, a study found – Insider AND High intake of refined grains linked to higher risk of heart disease and death – The BMJ

 


RCT: MRI-targeted biopsy safely reduces the need for biopsy in more than one-third of men at risk for prostate cancer

5 Feb, 2021 | 01:27h | UTC

Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial – JAMA Oncology

Commentary: Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard – Ontario Institute for Cancer Research AND Another Win for MRI and Targeted Prostate Biopsy – MedPage Today (free registration required)

Related: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis – New England Journal of Medicine (study and commentaries) Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis – European Urology AND Meta-Analysis: MRI plus Targeted Biopsy vs. Systematic Biopsy Alone for the Diagnosis of Prostate Cancer (studies and commentaries)

 


RCT: No difference in kidney allograft survival in kidney transplant patients allocated to early corticosteroid cessation vs. long-term corticosteroid therapy

5 Feb, 2021 | 01:26h | UTC

Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients: Long-term Outcomes of a Randomized Clinical Trial – JAMA Surgery (free for a limited period)

Commentary: Long-Term Corticosteroids Not Necessary After Kidney Transplant – Physician’s Weekly AND Is it OK to Cut Back on Prednisone After Kidney Transplant? – MedPage Today (free registration required)

 

Commentary on Twitter

 


Opinion: Peer reviewers—time for mass rebellion?

5 Feb, 2021 | 01:24h | UTC

Richard Smith: Peer reviewers—time for mass rebellion? – The BMJ Opinion

 


Health in dust belt cities and beyond

5 Feb, 2021 | 01:29h | UTC

Health in dust belt cities and beyond—an essay by Nick Middleton – The BMJ

 

Commentary on Twitter

 


5 things we learned about peer review in 2020

5 Feb, 2021 | 01:25h | UTC

5 Things We Learned About Peer Review in 2020 – Absolutely Maybe

 


Review: Dysphagia in older adults

5 Feb, 2021 | 01:22h | UTC

Dysphagia in Older Adults – Mayo Clinic Proceedings

 


Telemedicine and team-based care: The perils and the promise

5 Feb, 2021 | 01:23h | UTC

Telemedicine and Team-Based Care – Mayo Clinic Proceedings

 


The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer

5 Feb, 2021 | 01:19h | UTC

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer – JACC: CardioOncology

See also: Management of Immune Checkpoint Inhibitor–Induced Myocarditis: The French Working Group’s Plea for a Pragmatic Approach – JACC: CardioOncology

Commentary: JACC: CardioOncology Papers Discuss Evolving Landscape of Immune Checkpoint Inhibitors – American College of Cardiology

 


SR/MA: Colistin nephrotoxicity

5 Feb, 2021 | 01:21h | UTC

Colistin Nephrotoxicity: Meta-analysis of Randomized Controlled Trials – Open Forum Infectious Diseases

 


Opinion: Vaccine Nationalism Harms Everyone and Protects No One

5 Feb, 2021 | 01:45h | UTC

Vaccine Nationalism Harms Everyone and Protects No One – Foreign Policy

Related: Jeremy Farrar: Until we are all safe, no one is safe. Covid is a global problem – The Guardian AND Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations – The BMJ AND ‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly – Science AND WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access – United Nations

 


NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19”

5 Feb, 2021 | 01:44h | UTC

The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Tocilizumab (and Other Interleukin-6 Inhibitors) for the Treatment of COVID-19 – National Institutes of Health

 


Study: Adults between 20 and 49 years responsible for most Covid-19 spread

5 Feb, 2021 | 01:43h | UTC

Age groups that sustain resurging COVID-19 epidemics in the United States – Science

Commentaries: Adults 20 to 49 may have driven 72% of US COVID-19 surges – CIDRAP AND Younger adults responsible for most of COVID-19 spread: Study – ABC News

 


Study: Single dose Pfizer Covid-19 vaccine effectiveness estimated at 90% after 21 days

5 Feb, 2021 | 01:43h | UTC

Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel. – medRxiv

Commentaries: One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days – The Guardian AND Expert reaction to preprint reanalysing study of real-world Pfizer vaccination outcomes after one dose from Israel – Science Media Centre

 

Commentary on Twitter

 


Phase 1/2 Clinical Trial: CoronaVac is safe and well tolerated in older adults. Neutralizing antibodies were detected in over 90% of participants in all groups

5 Feb, 2021 | 01:41h | UTC

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – The Lancet Infectious Diseases

Commentary: Inactivated COVID-19 vaccines to make a global impact – The Lancet Infectious Diseases

 

Commentary on Twitter

 


New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

5 Feb, 2021 | 01:41h | UTC

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work – The Conversation

 


Impact of COVID-19 on cancer care has been ‘profound’, warns UN health agency

5 Feb, 2021 | 01:38h | UTC

Impact of COVID-19 on cancer care has been ‘profound’, warns UN health agency  – UN News

 


Dialysis patients have 4-fold greater risk of dying from COVID-19

5 Feb, 2021 | 01:39h | UTC

News Release: Dialysis patients have 4-fold greater risk of dying from COVID-19 – Canadian Medical Association Journal

Original Study: COVID-19 in patients undergoing long-term dialysis in Ontario – Canadian Medical Association Journal

 


Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either

5 Feb, 2021 | 01:40h | UTC

Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either – CTV News

Related: The world needs a single naming system for coronavirus variants – Nature

 


COVID’s mental-health toll: how scientists are tracking a surge in depression

5 Feb, 2021 | 01:36h | UTC

COVID’s mental-health toll: how scientists are tracking a surge in depression – Nature

Related: Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic – JAMA Psychiatry AND Mental Health, COVID-19, and the Invisible Pandemic on the Horizon – Mayo Clinic Proceedings

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.